Collagenase Clostridium Histolyticum in the Treatment of Urologic Disease: Current and Future Impact.
Sign Up to like & getrecommendations! Published in 2018 at "Sexual medicine reviews"
DOI: 10.1016/j.sxmr.2017.03.005
Abstract: INTRODUCTION Peyronie's disease (PD) is a connective tissue disorder resulting in the abnormal accumulation of type I to III collagen, fibrin, and disorganized elastic fibers in the tunica albuginea of the penis. Many medical and… read more here.
Keywords: treatment urologic; collagenase clostridium; clostridium histolyticum; treatment ... See more keywords
CAR-T Cells in the Treatment of Urologic Neoplasms: Present and Future
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.915171
Abstract: In recent years, with the breakthrough of CAR-T cells in the treatment of hematological tumors, they are increasingly being used to treat solid tumors, including urologic neoplasms. There are many relatively specific targets for urologic… read more here.
Keywords: urologic neoplasms; treatment urologic; car; cells treatment ... See more keywords
Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1071030
Abstract: At present, studies have found that c-Met is mainly involved in epithelial-mesenchymal transition (EMT) of tumor tissues in urologic neoplasms. Hepatocyte growth factor (HGF) combined with c-Met promotes the mitosis of tumor cells, and then… read more here.
Keywords: targeting met; urologic neoplasms; treatment urologic; neoplasms current ... See more keywords